Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum
- 1 October 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 84 (1-2) , 17-24
- https://doi.org/10.1016/0014-2999(82)90152-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Application of an irreversible opiate antagonist (β-FNA, β-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sitesLife Sciences, 1982
- Isolation and structure of dynorphin, an opioid peptide, from porcine duodenumNature, 1982
- The preference of putative pro-enkephalins for different types of opiate receptorsLife Sciences, 1981
- Rabbit vas deferens: A specific bioassay for opioid κ-receptor agonistsEuropean Journal of Pharmacology, 1981
- Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047Biochemical and Biophysical Research Communications, 1981
- Dynorphin interaction at the κ-opiate siteEuropean Journal of Pharmacology, 1981
- Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexusNature, 1981
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977